The biological functions of T helper 17 cell effector cytokines in inflammation.
暂无分享,去创建一个
[1] R. Locksley. The Roaring Twenties. , 2008, Immunity.
[2] S. Sidhu,et al. Regulation of a Late Phase of T Cell Polarity and Effector Functions by Crtam , 2008, Cell.
[3] M. Fei,et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.
[4] S. Sa,et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.
[5] S. Brand,et al. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL‐22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status , 2008, Inflammatory bowel diseases.
[6] L. Fouser,et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. , 2008, The Journal of clinical investigation.
[7] R. Xavier,et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.
[8] Robert W. Williams,et al. Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.
[9] U. Grohmann,et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease , 2008, Nature.
[10] B. Becher,et al. IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.
[11] Y. Li,et al. Cytokine-Mediated Regulation of Human B Cell Differentiation into Ig-Secreting Cells: Predominant Role of IL-21 Produced by CXCR5+ T Follicular Helper Cells1 , 2007, The Journal of Immunology.
[12] L. Fouser,et al. An IL-17F/A Heterodimer Protein Is Produced by Mouse Th17 Cells and Induces Airway Neutrophil Recruitment , 2007, The Journal of Immunology.
[13] Robert M. Anthony,et al. Protective immune mechanisms in helminth infection , 2007, Nature Reviews Immunology.
[14] R. Wu,et al. Requirement for Both JAK-Mediated PI3K Signaling and ACT1/TRAF6/TAK1-Dependent NF-κB Activation by IL-17A in Enhancing Cytokine Expression in Human Airway Epithelial Cells1 , 2007, The Journal of Immunology.
[15] A. Murphy,et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. , 2007, Immunity.
[16] T. Macdonald,et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease , 2007, Gut.
[17] Scott R. Presnell,et al. Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F , 2007, The Journal of Immunology.
[18] Nathalie Arbour,et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.
[19] Francesco Bistoni,et al. IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance , 2007, European journal of immunology.
[20] T. Hamilton,et al. IL-17 Enhances Chemokine Gene Expression through mRNA Stabilization1 , 2007, The Journal of Immunology.
[21] D. Levy,et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.
[22] Kathleen M. Smith,et al. Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.
[23] P. Lipsky,et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus , 2007, Annals of the rheumatic diseases.
[24] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[25] Terry B. Strom,et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.
[26] A. D. Panopoulos,et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells , 2007, Nature.
[27] M. Brahic,et al. Interleukin 22 Is a Candidate Gene for Tmevp3, a Locus Controlling Theiler's Virus-Induced Neurological Diseases , 2007, Genetics.
[28] P. Deloukas,et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21 , 2007, Nature Genetics.
[29] M. Romano,et al. IL-21 Is Highly Produced in Helicobacter pylori-Infected Gastric Mucosa and Promotes Gelatinases Synthesis1 , 2007, The Journal of Immunology.
[30] K. Asadullah,et al. IL-22 Induces Lipopolysaccharide-Binding Protein in Hepatocytes: A Potential Systemic Role of IL-22 in Crohn’s Disease , 2007, The Journal of Immunology.
[31] R. Locksley,et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.
[32] R. Kastelein,et al. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. , 2007, Annual review of immunology.
[33] R. D. Hatton,et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. , 2007, Annual review of immunology.
[34] M. Collins,et al. IL-21 Has a Pathogenic Role in a Lupus-Prone Mouse Model and Its Blockade with IL-21R.Fc Reduces Disease Progression , 2007, The Journal of Immunology.
[35] D. Hommes,et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease , 2007, Inflammatory bowel diseases.
[36] V. Tuohy,et al. The adaptor Act1 is required for interleukin 17–dependent signaling associated with autoimmune and inflammatory disease , 2007, Nature Immunology.
[37] Mark J. Smyth,et al. IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production1 , 2007, The Journal of Immunology.
[38] James G. Krueger,et al. Pathogenesis and therapy of psoriasis , 2007, Nature.
[39] S. Sa,et al. The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis , 2007, The Journal of Immunology.
[40] M. Lebwohl,et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. , 2007, The New England journal of medicine.
[41] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[42] Steven J. Schrodi,et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.
[43] J. Kolls,et al. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[44] B. Holzmann,et al. Inhibition of Interleukin-22 Attenuates Bacterial Load and Organ Failure during Acute Polymicrobial Sepsis , 2007, Infection and Immunity.
[45] D. Missé,et al. IL-22 Participates in an Innate Anti-HIV-1 Host-Resistance Network through Acute-Phase Protein Induction1 , 2007, The Journal of Immunology.
[46] C. Dong,et al. Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor* , 2006, Journal of Biological Chemistry.
[47] Qiang Tian,et al. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes , 2006, Cell Research.
[48] L. Fouser,et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.
[49] J. Miyazaki,et al. Hydrodynamic-Based Delivery of an Interleukin-22-Ig Fusion Gene Ameliorates Experimental Autoimmune Myocarditis in Rats1 , 2006, The Journal of Immunology.
[50] Zihua Hu,et al. Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.
[51] L. Hooper,et al. Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.
[52] F. Powrie,et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.
[53] J. Derry,et al. Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex , 2006, The Journal of Immunology.
[54] S. Nakae,et al. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[55] Q. Zhong,et al. IL-17 Receptor Knockout Mice Have Enhanced Myelotoxicity and Impaired Hemopoietic Recovery Following Gamma Irradiation , 2006, The Journal of Immunology.
[56] T. Macdonald,et al. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 , 2006, Gut.
[57] J. Kolls,et al. Critical role of IL‐17 receptor signaling in acute TNBS‐induced colitis , 2006, Inflammatory bowel diseases.
[58] T. Mcclanahan,et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.
[59] K. Asadullah,et al. IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.
[60] R. D. Hatton,et al. Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.
[61] K. Herrmann,et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[62] J. Shellito,et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae , 2005, The Journal of experimental medicine.
[63] A. Takayanagi,et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. , 2005, Gastroenterology.
[64] C. Brooks,et al. Multiple Cytokines Regulate the NK Gene Complex-Encoded Receptor Repertoire of Mature NK Cells and T Cells1 , 2005, The Journal of Immunology.
[65] J. Kolls,et al. Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis 1 , 2005, The Journal of Immunology.
[66] J. Derry,et al. Nectin-like Protein 2 Defines a Subset of T-cell Zone Dendritic Cells and Is a Ligand for Class-I-restricted T-cell-associated Molecule*♦ , 2005, Journal of Biological Chemistry.
[67] R. Copley,et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.
[68] K. Hiromura,et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. , 2005, Arthritis and rheumatism.
[69] A. Gurney,et al. IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.
[70] U. Müller-Ladner,et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. , 2005, Arthritis and rheumatism.
[71] T. Macdonald,et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. , 2005, Gastroenterology.
[72] K. Ley,et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. , 2005, Immunity.
[73] F. Shi,et al. Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen1 , 2005, The Journal of Immunology.
[74] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[75] J. Berzofsky,et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function , 2005, The Journal of experimental medicine.
[76] J. Schwartzman,et al. Interleukin-17/Interleukin-17 Receptor-Mediated Signaling Is Important for Generation of an Optimal Polymorphonuclear Response against Toxoplasma gondii Infection , 2005, Infection and Immunity.
[77] Shizuo Akira,et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.
[78] A. Gottlieb,et al. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. , 2004, The Journal of investigative dermatology.
[79] M. Grusby,et al. Biology of IL‐21 and the IL‐21 receptor , 2004, Immunological reviews.
[80] P. Lipsky,et al. Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-61 , 2004, The Journal of Immunology.
[81] R. Wu,et al. IL-17 Markedly Up-Regulates β-Defensin-2 Expression in Human Airway Epithelium via JAK and NF-κB Signaling Pathways1 , 2004, The Journal of Immunology.
[82] K. Asadullah,et al. IL-22 increases the innate immunity of tissues. , 2004, Immunity.
[83] P. Schwarzenberger,et al. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.
[84] C. Mackay,et al. T Follicular Helper Cells Express a Distinctive Transcriptional Profile, Reflecting Their Role as Non-Th1/Th2 Effector Cells That Provide Help for B Cells1 , 2004, The Journal of Immunology.
[85] T. Malek,et al. Distinct Activation Signals Determine whether IL-21 Induces B Cell Costimulation, Growth Arrest, or Bim-Dependent Apoptosis1 , 2004, The Journal of Immunology.
[86] R. Sun,et al. Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.
[87] N. Sarvetnick,et al. Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity , 2004, Cell.
[88] L. Armstrong,et al. Interleukin-22: a potential immunomodulatory molecule in the lung. , 2004, American journal of respiratory cell and molecular biology.
[89] C. D. Krause,et al. Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.
[90] Lauren Cohn,et al. Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.
[91] S. Nutt,et al. IL-21 Induces the Functional Maturation of Murine NK Cells 1 , 2004, The Journal of Immunology.
[92] L. Joosten,et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. , 2004, Arthritis and rheumatism.
[93] Ju-Young Kim,et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways , 2004, Arthritis research & therapy.
[94] M. Dhodapkar,et al. Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.
[95] W. Leonard,et al. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. , 2003, Cancer research.
[96] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[97] D. Foster,et al. Interleukin-21 inhibits dendritic cell activation and maturation. , 2003, Blood.
[98] L. Moretta,et al. IL‐21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig‐like receptors , 2003, European journal of immunology.
[99] R. Paus,et al. Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. , 2003, The Journal of investigative dermatology.
[100] M. Zago,et al. The Profile of Gene Expression of Human Marrow Mesenchymal Stem Cells , 2003, Stem cells.
[101] D. Foster,et al. Cytokine requirements for the growth and development of mouse NK cells in vitro , 2003, Journal of leukocyte biology.
[102] G. Bouma,et al. The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.
[103] Y. Ho,et al. Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.
[104] E. Lubberts. The role of IL-17 and family members in the pathogenesis of arthritis. , 2003, Current opinion in investigational drugs.
[105] J. Lötvall,et al. Endogenous IL-17 as a Mediator of Neutrophil Recruitment Caused by Endotoxin Exposure in Mouse Airways1 , 2003, The Journal of Immunology.
[106] Frank Eisenhaber,et al. The STIR-domain superfamily in signal transduction, development and immunity. , 2003, Trends in biochemical sciences.
[107] T. Moseley,et al. Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.
[108] J. Lötvall,et al. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. , 2003, European journal of pharmacology.
[109] D. Kasper,et al. CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism 1 , 2003, The Journal of Immunology.
[110] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[111] A. Gurney,et al. Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.
[112] A. Andoh,et al. Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.
[113] Kotaro Suzuki,et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cε transcription of IL-4–stimulated B cells , 2002 .
[114] A. Sher,et al. A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.
[115] D. Sacks,et al. The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.
[116] H. Yssel,et al. IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells. , 2002, International immunology.
[117] A. Satoskar,et al. Interleukin 21 Is a T Helper (Th) Cell 2 Cytokine that Specifically Inhibits the Differentiation of Naive Th Cells into Interferon γ–producing Th1 Cells , 2002, The Journal of experimental medicine.
[118] D. Foster,et al. IL-21 Up-Regulates the Expression of Genes Associated with Innate Immunity and Th1 Response1 , 2002, The Journal of Immunology.
[119] Diane Lejeune,et al. Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line , 2002, The Journal of Biological Chemistry.
[120] J. Renauld,et al. Crystal structure of recombinant human interleukin-22. , 2002, Structure.
[121] K. Weinberg,et al. The Common γ Chain (γc) Is a Required Signaling Component of the IL-21 Receptor and Supports IL-21-Induced Cell Proliferation via JAK3† , 2002 .
[122] R. Coffman,et al. New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.
[123] K. Asadullah,et al. Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.
[124] Katie Chan,et al. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.
[125] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[126] M. Collins,et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. , 2002, Immunity.
[127] S. Kotenko,et al. Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.
[128] B. Kirkham,et al. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. , 2002, Arthritis and rheumatism.
[129] T. Moseley,et al. Soluble and Transmembrane Isoforms of Novel Interleukin-17 Receptor-like Protein by RNA Splicing and Expression in Prostate Cancer* , 2002, The Journal of Biological Chemistry.
[130] K. Ley,et al. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. , 2001, Blood.
[131] A. Gurney,et al. Acinar cells of the pancreas are a target of interleukin-22. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[132] M. Kawaguchi,et al. Modulation of bronchial epithelial cells by IL-17. , 2001, The Journal of allergy and clinical immunology.
[133] G. Sledge,et al. Cutting Edge: IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production1 , 2001, The Journal of Immunology.
[134] R. Kelley,et al. IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding , 2001, The EMBO journal.
[135] D. Lejeune,et al. Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types1 , 2001, The Journal of Immunology.
[136] J. Shellito,et al. Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.
[137] Scott R. Presnell,et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[138] H. Asao,et al. Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex1 , 2001, The Journal of Immunology.
[139] D. Lejeune,et al. Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22 , 2001, The Journal of Immunology.
[140] S. Pestka,et al. Identification, Cloning, and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity1 2 , 2001, The Journal of Immunology.
[141] J. Lötvall,et al. IL‐17‐induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen‐activated protein (MAP) kinases , 2001, British journal of pharmacology.
[142] S. Pestka,et al. Identification of the Functional Interleukin-22 (IL-22) Receptor Complex , 2001, The Journal of Biological Chemistry.
[143] D. Conklin,et al. Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.
[144] M. Byrne,et al. Microbial Lipopeptides Induce the Production of IL-17 in Th Cells1 , 2000, The Journal of Immunology.
[145] Scott R. Presnell,et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.
[146] J Wagner,et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.
[147] W. Leonard,et al. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[148] Zemin Zhang,et al. Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R* , 2000, The Journal of Biological Chemistry.
[149] J. Renauld,et al. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[150] L. Glimcher,et al. Lineage commitment in the immune system: the T helper lymphocyte grows up. , 2000, Genes & development.
[151] J. Kolls,et al. Requirement of Endogenous Stem Cell Factor and Granulocyte-Colony-Stimulating Factor for IL-17-Mediated Granulopoiesis1 , 2000, The Journal of Immunology.
[152] Jamila Louahed,et al. Cloning and Characterization of IL-10-Related T Cell-Derived Inducible Factor (IL-TIF), a Novel Cytokine Structurally Related to IL-10 and Inducible by IL-91 , 2000, The Journal of Immunology.
[153] J. Lötvall,et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.
[154] A. Miller,et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. , 1998, Journal of immunology.
[155] R. de Waal Malefyt,et al. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. , 1998, The Journal of investigative dermatology.
[156] S. Narula,et al. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. , 1998, Immunology letters.
[157] J. Todd,et al. Mapping of the IDDM Locus Idd3 to a 0.35-cM Interval Containing the Interleukin-2 Gene , 1997, Diabetes.
[158] J. Banchereau,et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines , 1996, The Journal of experimental medicine.
[159] F. Denizot,et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. , 1993, Journal of immunology.
[160] J. Dagorn,et al. Messenger RNA sequence and expression of rat pancreatitis-associated protein, a lectin-related protein overexpressed during acute experimental pancreatitis. , 1991, The Journal of biological chemistry.
[161] Jia Newcombe,et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.
[162] K. Ley,et al. IL-17A-producing neutrophil-regulatory Tn lymphocytes , 2006, Immunologic research.
[163] R. Coffman,et al. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.